Shannette Keeler, LCSW, PC in Plain City, UT - Medicare Clinical Social Worker Provider

Shannette Keeler, LCSW, PC is a medicare enrolled "Social Worker - Clinical" provider in Plain City, Utah. She graduated from medical school in 1982 and has 42 years of diverse experience with area of expertise as Clinical Social Worker. Her current practice location is 4184 W 1975 N, Plain City, Utah. You can reach out to her office (for appointments etc.) via phone at (801) 732-1102.

Shannette Keeler is licensed to practice in Utah (license number 135206-3501) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1255497376.

Contact Information

	Shannette Keeler, LCSW, PC
	4184 W 1975 N, Plain City, UT 84404-9716
	(801) 732-1102
	(801) 732-1107

Healthcare Provider's Profile

Full Name	Shannette Keeler
Gender	Female
Speciality	Clinical Social Worker
Experience	42 Years
Location	4184 W 1975 N, Plain City, Utah
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Shannette Keeler graduated from medical school in 1982

NPI Data:

NPI Number: 1255497376
Provider Enumeration Date: 01/01/2007
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 6406822923
Enrollment ID: I20040907000840

Medical Identifiers

Medical identifiers for Shannette Keeler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255497376	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	135206-3501 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shannette Keeler is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shannette Keeler, LCSW, PC 4184 W 1975 N, Plain City, UT 84404-9716 Ph: (801) 732-1102	Shannette Keeler, LCSW, PC 4184 W 1975 N, Plain City, UT 84404-9716 Ph: (801) 732-1102

News Archive

New research reverses the understanding of kidney tumor growth

Newly published research has reversed our understanding of an aspect of kidney tumor growth. Researchers at Huntsman Cancer Institute at the University of Utah (U of U) discovered that two key proteins have opposite roles than what was previously believed.

Nevro to initiate Senza HF-SCS System study for chronic pain

Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.

Human Genome Sciences achieves systemic lupus goals with candidate drug

Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.

Study calls for earlier use of ICDs in patients diagnosed with cardiomyopathy

A study presented today at the Late Breaking Clinical Trials presentations at the Heart Rhythm Society's Annual Scientific Sessions in New Orleans found that implantable cardiac defibrillators (ICD) benefit patients with recently diagnosed cardiomyopathy, a disease that affects the heart muscle's ability to pump and can lead to heart failure.

Study shows benefits of delayed-release stimulant in children with ADHD

A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.

Shannette Keeler, LCSW, PC - Medicare Clinical Social Worker in Plain City, UT